Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
24.14
+0.28 (1.17%)
Mar 6, 2026, 4:08 PM HKT
HKG:6826 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 2,629 | 2,740 | 2,542 | 2,901 |
Short-Term Investments | - | 46.94 | 23.58 | 13.32 | 12.18 |
Trading Asset Securities | - | 87.85 | 11.08 | - | 6.38 |
Cash & Short-Term Investments | 2,599 | 2,764 | 2,775 | 2,555 | 2,919 |
Cash Growth | -5.97% | -0.38% | 8.60% | -12.48% | -6.20% |
Accounts Receivable | - | 324.28 | 337.08 | 388.28 | 375.21 |
Other Receivables | - | - | - | - | 7 |
Receivables | - | 324.28 | 337.08 | 388.28 | 382.21 |
Inventory | - | 490.65 | 526.17 | 485.24 | 354.77 |
Other Current Assets | - | 79.25 | 112.23 | 103.56 | 56.27 |
Total Current Assets | - | 3,658 | 3,750 | 3,532 | 3,713 |
Property, Plant & Equipment | - | 1,895 | 1,615 | 1,509 | 1,412 |
Long-Term Investments | - | 501.03 | 607.1 | 671.44 | 625.35 |
Goodwill | - | 422.93 | 413.02 | 411.2 | 406.9 |
Other Intangible Assets | - | 559.88 | 574.88 | 620.42 | 613.4 |
Long-Term Deferred Tax Assets | - | 59.3 | 53.12 | 59.32 | 49.36 |
Other Long-Term Assets | - | 25.34 | 92.19 | 89.07 | 130.93 |
Total Assets | - | 7,121 | 7,105 | 6,892 | 6,950 |
Accounts Payable | - | 62.1 | 55.11 | 157.87 | 46.26 |
Accrued Expenses | - | 196.22 | 198.13 | 153.7 | 174.5 |
Short-Term Debt | - | 211.5 | 10 | 5.31 | 48.78 |
Current Portion of Long-Term Debt | - | 75.59 | 186.32 | 7.71 | 0.13 |
Current Portion of Leases | - | 18.6 | 20.31 | 21.36 | 17.11 |
Current Income Taxes Payable | - | 17.4 | 34.4 | 24.65 | 1.26 |
Current Unearned Revenue | - | 196.09 | 124.69 | 83.51 | 107.42 |
Other Current Liabilities | - | 88.4 | 87 | 57.17 | 91.82 |
Total Current Liabilities | - | 865.89 | 715.95 | 511.28 | 487.27 |
Long-Term Debt | - | 110.72 | 157.44 | 43.98 | 9.89 |
Long-Term Leases | - | 32.02 | 33.88 | 39.9 | 29.61 |
Long-Term Unearned Revenue | - | 15.41 | 13.63 | 5.5 | 9.4 |
Long-Term Deferred Tax Liabilities | - | 151.77 | 161.67 | 163.51 | 157.91 |
Other Long-Term Liabilities | - | 28.54 | 5.64 | 225.85 | 195.99 |
Total Liabilities | - | 1,204 | 1,088 | 990.02 | 890.07 |
Common Stock | - | 233.19 | 171.48 | 174.13 | 175.82 |
Additional Paid-In Capital | - | 2,776 | 2,981 | 3,003 | 3,091 |
Retained Earnings | - | 2,981 | 2,818 | 2,458 | 2,399 |
Treasury Stock | - | -228.34 | -248.46 | -74.04 | - |
Comprehensive Income & Other | - | -186.42 | -71.71 | -47.02 | 47.87 |
Total Common Equity | 5,616 | 5,575 | 5,650 | 5,515 | 5,713 |
Minority Interest | - | 341.78 | 367.23 | 387.77 | 346.83 |
Shareholders' Equity | 5,884 | 5,917 | 6,017 | 5,902 | 6,060 |
Total Liabilities & Equity | - | 7,121 | 7,105 | 6,892 | 6,950 |
Total Debt | 412.88 | 448.43 | 407.95 | 118.26 | 105.51 |
Net Cash (Debt) | 2,186 | 2,316 | 2,367 | 2,437 | 2,814 |
Net Cash Growth | -5.59% | -2.16% | -2.88% | -13.40% | -6.34% |
Net Cash Per Share | 9.41 | 9.93 | 9.97 | 7.16 | 8.15 |
Filing Date Shares Outstanding | 231.99 | 230.04 | 233.93 | 239.78 | 246.15 |
Total Common Shares Outstanding | 231.99 | 230.49 | 233.93 | 239.78 | 246.15 |
Working Capital | - | 2,792 | 3,034 | 3,021 | 3,225 |
Book Value Per Share | 24.02 | 24.19 | 24.15 | 23.00 | 23.21 |
Tangible Book Value | 4,530 | 4,592 | 4,662 | 4,483 | 4,693 |
Tangible Book Value Per Share | 19.38 | 19.92 | 19.93 | 18.70 | 19.07 |
Land | - | 391.02 | 365.66 | 346.25 | 359.38 |
Machinery | - | 950.12 | 893.54 | 807.78 | 750.86 |
Construction In Progress | - | 903.04 | 635.61 | 520.22 | 369.57 |
Leasehold Improvements | - | - | - | - | 139.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.